Business · 01/02/2019

FDA Announces Draft Guidance for Industry on Abbreviated New Drug Application Submissions and Requests

The FDA is releasing a draft guidance to help industry prepare and submit amendments to tentatively approved abbreviated new drug applications, aiming to facilitate final approval on the earliest lawful date.